Global Estimates of COVID‐19 Morbidity and Mortality: A Cohort Study and Mathematical Model Analysis
Influenza and Other Respiratory Viruses · 2025
DOI: 10.1111/irv.70154 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Influenza and Other Respiratory Viruses, 2025. Verfasst von Houssein H Ayoub und 2 weiteren Autor:innen. Beteiligte Einrichtung: Mathematics Program, Department of Mathematics and Statistics, College of Arts and Sciences, Qatar University, Doha, Qatar. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar University, Qatar Research Development and Innovation Council, Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core.
Abstract (Originalsprache)
Background
The true extent of the severity and fatality caused by the COVID‐19 pandemic remains uncertain. This study provides an approximate estimate of the global disease burden from the pandemic.
Methods
A cohort study followed the Qatari population from the onset of the pandemic to March 18, 2024, to estimate the age‐specific incidence rates of severe, critical, and fatal COVID‐19, classified according to World Health Organization criteria. A mathematical model then utilized these rates to generate regional and global estimates of COVID‐19 severity and fatality.
Results
The incidence rate of any severe, critical, or fatal COVID‐19 throughout the pandemic was 1.13 (95% CI: 1.07–1.19) per 1000 person‐years, while that of fatal COVID‐19 alone was 0.11 (95% CI: 0.09–0.13) per 1000 person‐years. Globally, the number of severe, critical, or fatal COVID‐19 cases was estimated at 61.9 million (95% UI: 55.0–69.9 million), while the number of fatal COVID‐19 cases alone was estimated at 11.3 million (95% UI: 7.8–17.4 million). Both estimates showed large regional variations. Most severe, critical, and fatal COVID‐19 cases occurred during the pre‐Omicron phase of the pandemic.
Conclusions
The COVID‐19 pandemic had a profound global impact on morbidity and mortality, emphasizing the critical need for preparedness for future pandemics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mathematics Program, Department of Mathematics and Statistics, College of Arts and Sciences, Qatar University, Doha, Qatar.
- Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
- Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA.
- Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
- College of Health and Life Sciences, Hamad bin Khalifa University, Doha, Qatar.
ORCID-Profile: Houssein H Ayoub, Hiam Chemaitelly, Laith J Abu-Raddad
Förderung
- Qatar University
- Qatar Research Development and Innovation Council
- Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core
- Ministry of Public Health and Hamad Medical Corporation
- Junior Faculty Transition to Independence Program at Weill Cornell Medicine-Qatar
- L'Oréal-UNESCO For Women In Science Middle East Regional Young Talents Program
- Qatar Genome Programme
Zitieren
APA
Ayoub, H. H., Chemaitelly, H., & Abu-Raddad, L. J. (2025). Global Estimates of COVID‐19 Morbidity and Mortality: A Cohort Study and Mathematical Model Analysis. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70154
Vancouver
Ayoub HH, Chemaitelly H, Abu-Raddad LJ. Global Estimates of COVID‐19 Morbidity and Mortality: A Cohort Study and Mathematical Model Analysis. Influenza and Other Respiratory Viruses. 2025. doi:10.1111/irv.70154
BibTeX
@article{Ayoub2025,
author = {Ayoub, Houssein H and Chemaitelly, Hiam and Abu-Raddad, Laith J},
title = {Global Estimates of COVID‐19 Morbidity and Mortality: A Cohort Study and Mathematical Model Analysis},
journal = {Influenza and Other Respiratory Viruses},
year = {2025},
doi = {10.1111/irv.70154}
}
EUVIMED